I'm sorry to hear about your difficulties. Here is some information about Remodulin and its use for pulmonary hypertension:

Remodulin (Treprostinil)
- Purpose: Approved by the FDA to improve exercise capacity in pulmonary arterial hypertension (PAH).
- Mechanism:
- Dilates blood vessels in the lungs, increasing blood Show Full Answer

I'm sorry to hear about your difficulties. Here is some information about Remodulin and its use for pulmonary hypertension:

Remodulin (Treprostinil):
- Purpose: Approved by the FDA to improve exercise capacity in pulmonary arterial hypertension (PAH).
- Mechanism:
- Dilates blood vessels in the lungs, increasing blood flow and oxygen delivery.
- Slows scarring in lung blood vessels, delaying disease progression.
- Administration:
- Continuous infusion, either subcutaneously or intravenously.
- Subcutaneous infusion involves a catheter moved every three days.
- Intravenous infusion uses a Hickman or Groshong line, attached to a pump worn on the belt or as a backpack.
- Side Effects:
- Common: Skin reactions at infusion sites, headache, jaw pain, nausea, diarrhea, edema, hypotension.
- Serious: Risk of serious infection, including life-threatening sepsis with intravenous infusion.

Tadalafil:
- Purpose: Often added to treatment plans to help improve exercise capacity and reduce symptoms.
- Mechanism: Helps relax blood vessels in the lungs, making it easier for the heart to pump blood.

Current Time:
- Today: Friday, November 22nd, 2024.

If your breathing is getting worse, it's crucial to discuss this with your healthcare provider to adjust your treatment plan. For more details, you can visit the following resource: [Remodulin — United Therapeutics](https://www.remodulin.com).

 This AI-generated response comes from myPHteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Remodulin (Treprostinil) for Pulmonary Hypertension | myPHteam

PAH and Shortness of Breath: How Does Treatment Help? | myPHteam